Core & Main heads into the week as one of the cleaner stories in its sector right now — a stock down sharply from its highs, a Street that still sees meaningful upside, and a lending market with no pressure whatsoever.
The price action tells the first part of the story. CNM has fallen 12% over the past month to $45.75, with another 5% coming off just this week. That follows the June earnings print, which landed with a thud: management cut full-year adjusted EBITDA guidance to $920–$940M, well short of the Street's $980M expectation. The culprit was softening residential demand combined with higher operating costs — a combination that has rattled the whole waterworks distribution space. The selloff is not unique to CNM. Closest correlated peers BXC and WCC fell 15% and 11% respectively over the same week, while AIT dropped 6%. CNM's 5% weekly decline looks relatively contained by comparison, though that's a low bar.
The lending market offers no support to the bear case — and arguably undermines it. Short interest is a modest 4.8% of free float, roughly in the middle of its recent range after edging down 3% on the week. Borrowing costs remain very cheap at 0.52%, up about 20% on the week but still in historically low territory. Most tellingly, availability is enormous: roughly 877 shares remain available to borrow for every 100 already shorted, well above the 52-week floor of 723%. The borrow market is loose, not tight. The ORTEX short score holds around 42, middling and stable — no sign of a coordinated short build. Positioning looks skeptical rather than aggressive.
Options traders are leaning mildly bullish, which cuts against the recent price weakness. The put/call ratio at 0.59 is slightly below its 20-day average of 0.66 — call volume is running a touch heavier than normal given the month the stock has had. It's a subtle signal, but it implies options participants are not rushing to buy downside protection at current levels. The PCR z-score of -0.23 is trivially below average, making this a neutral-to-constructive read rather than a defensive one.
The Street remains broadly positive but has been trimming its ambitions. Citigroup lowered its target to $53 from $54 on June 11 — still a Neutral rating — making it the most recent action on file. Before that, Deutsche Bank and Barclays both maintained constructive ratings while shaving targets modestly in March. The mean target across the analyst community stands at $60.60, implying roughly 32% upside from current levels. Bulls point to gross margin expansion of 40 basis points to 26.8% and 6.6% net sales growth driven by volume, arguing SG&A headwinds are near their peak. Bears counter that the EBITDA guidance revision signals structural pressure in residential end-markets that won't resolve quickly. With EV/EBITDA running around 11x and a forward P/E near 16x, the valuation is not demanding for a distributor — but those multiples assume a recovery in volumes that isn't yet visible. EPS momentum factor scores tell a more interesting story: the 30-day reading ranks in the 96th percentile, suggesting estimate revisions have recently turned positive even after the guidance cut.
Institutional ownership is stable. BlackRock holds just over 10% and added modestly in the most recent quarter. Capital Research added significantly — over 5 million shares — bringing its stake to 6.2%. The insider picture is largely routine: an independent director bought roughly $100K worth of stock at $50.70 in early April, while the CFO made small scheduled sales around the same period. Neither move is large enough to read as a directional signal.
The next visible catalyst is the following quarterly print. With no earnings date yet confirmed, the key question between now and then is whether residential demand data — housing starts, municipal project awards — shows any sequential stabilisation or continues to deteriorate on the pace that prompted the guidance cut.
See the live data behind this article on ORTEX.
Open CNM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
